Hangzhou Phecdamed Co., Ltd.

This study tests a new capsule, TJ0113, in 204 older adults (age 60+) with sarcopenia, a condition causing muscle loss and weakness. Participants take the capsule or a placebo daily for 26 weeks. The main goal is to see if the drug improves walking speed, a key measure of muscle …

This phase 2 trial tests an experimental drug called TJ0113 for people with depression. About 150 adults aged 18 to 65 will take either 200 mg or 400 mg of TJ0113 or a placebo daily for 8 weeks. Researchers will measure changes in depression symptoms using a standard rating scale…